Long Alison S 4
4 · Taysha Gene Therapies, Inc. · Filed Nov 3, 2023
Insider Transaction Report
Form 4
Long Alison S
Director
Transactions
- Award
Stock Option (right to buy)
2023-11-01+43,800→ 43,800 totalExercise: $2.38Exp: 2033-11-01→ Common Stock (43,800 underlying)
Footnotes (1)
- [F1]The shares vest in 36 equal monthly installments commencing on December 1, 2023 such that the shares will be fully vested on November 1, 2026, subject to the Reporting Person's continued service as a director through the applicable vesting date.